Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs)

被引：20

作者：

Klotz, Ulrich ^{[1
,2
]}

机构：

[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany

[2] Univ Tubingen, Tubingen, Germany

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 65卷 / 01期

关键词：

CLOPIDOGREL; ESOMEPRAZOLE; RABEPRAZOLE; METABOLISM; GENOTYPE;

D O I：

10.1007/s00228-008-0571-x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 2

页数：2

共 14 条

[1] Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin
Gilard, Martine
Arnaud, Bertrand
Cornily, Jean-Christophe
Le Gal, Gregoire
Lacut, Karine
Le Calvez, Genevive
Mansourati, Jacques
Mottier, Dominique
Abgrall, Jean-Francois
Boschat, Jacques
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) : 256 - 260
[2] A possible new candidate influencing the antiplatelet effect of clopidogrel
Gurbel, Paul A.
Lau, Wei C.
Tantry, Udaya S.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) : 261 - 263
[3] Review article: relationship between the metabolism and efficacy of proton pump inhibitors - focus on rabeprazole
Horn, J
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 11 - 19
[4] Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
Hulot, Jean-Sebastien
Bura, Alessandra
Villard, Eric
Azizi, Michel
Remones, Veronique
Goyenvalle, Catherine
Aiach, Martine
Lechat, Philippe
Gaussem, Pascale
[J]. BLOOD, 2006, 108 (07) : 2244 - 2247
[5] The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH
Junghard, O
Hassan-Alin, M
Hasselgren, G
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : 453 - 458
[6] Pharmacogenetics-based therapeutic recommendations -: ready for clinical practice?
Kirchheiner, J
Fuhr, U
Brockmöller, J
[J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (08) : 639 - 647
[7] CYPC19 polymorphism and proton pump inhibitors
Klotz, U
Schwab, M
Treiber, G
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 95 (01) : 2 - 8
[8] Klotz U, 2006, INT J CLIN PHARM TH, V44, P297
[9] LOU HY, 2008, EUR J CLIN IN PRESS
[10] Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19:: Evidence from clinical and pharmacokinetic data
Schwab, M
Klotz, U
Hofmann, U
Schaeffeler, E
Leodolter, A
Malfertheiner, P
Treiber, G
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) : 627 - 634

← 1 2 →